A Phase I Study Of PV701 In Patients With Head And Neck Squamous Cell Carcinoma
Phase of Trial: Phase I
Latest Information Update: 23 Jan 2013
At a glance
- Drugs PV 701 (Primary)
- Indications Head and neck cancer
- Focus Adverse reactions
- 23 Jan 2013 Status changed from completed to discontinued as reported by ClinicalTrials.gov.
- 11 Aug 2008 New trial record.